首页
(current)
大学
论文
新闻
招聘
FAQ
简体中文
中
En
登录
注册
#Subhasree Nag
Abstract 5266: RYBP expression predicts survival of patients with hepatocellular carcinoma, and regulates response to chemotherapy
胃癌基础与临床转化研究实验室 , 中国科学院
miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents
胃癌基础与临床转化研究实验室 , 中国科学院
The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models
胃癌基础与临床转化研究实验室 , 中国科学院
Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
胃癌基础与临床转化研究实验室 , 中国科学院
A quantitative LC-MS/MS method for determination of SP-141, a novel pyrido[b]indole anticancer agent, and its application to a mouse PK study
胃癌基础与临床转化研究实验室 , 中国科学院
Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications
胃癌基础与临床转化研究实验室 , 中国科学院
Development and validation of an HPLC-MS/MS analytical method for quantitative analysis of TCBA-TPQ, a novel anticancer makaluvamine analog, and application in a pharmacokinetic study in rats
胃癌基础与临床转化研究实验室 , 中国科学院
NFAT as cancer target: Mission possible?
胃癌基础与临床转化研究实验室 , 中国科学院
Development and validation of a rapid HPLC method for quantitation of SP-141, a novel pyrido[b]indole anticancer agent, and an initial pharmacokinetic study in mice
胃癌基础与临床转化研究实验室 , 中国科学院
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
胃癌基础与临床转化研究实验室 , 中国科学院
Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.
胃癌基础与临床转化研究实验室 , 中国科学院